Yulu Chen

Yulu Chen

Auto-generated profile, based on publicly available information

Yulu Chen

Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, MA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2023 in Allergy
Verified
Journal Article
Closed access
YCYulu Chen
Yulu Chen
ACAntonio Checa
Antonio Checa
PZPei Zhang
Pei Zhang
MHMengna Huang
Mengna Huang
Rachel KellyRachel Kelly
Rachel Kelly
JLJessica A. Lasky‐Su
Jessica A. Lasky‐Su

1 January 2023 in Journal of Animal Science
Verified
Journal Article
Open access
PDF file
YCYulu Chen
Yulu Chen
SLSteven Lonergan
Steven Lonergan
KLKyu-Sang Lim
Kyu-Sang Lim
JCJian Cheng
Jian Cheng
APAustin M Putz
Austin M Putz
JDJack Dekkers
Jack Dekkers
Selection for disease resilience, which refers to the ability of an animal to maintain performance when exposed to disease, can reduce the impact of infectious diseases. However, direct selection for disease resilience is challenging because nucleus herds must maintain a high health status. A possible solution is indirect selection on indicators of disease resilience. To search for such indicators, we conducted phenotypic and genetic quantitative analyses of the abundances of 377 proteins in plasma samples from 912 young and visually healthy pigs and their relationships with performance and subsequent disease resilience after natural exposure to a polymicrobial disease challenge. Abundances of 100 proteins were significantly heritable (false discovery rate (FDR) <0.10). The abundance of some proteins was or tended to be genetically correlated (rg) with disease resilience, including complement system proteins (rg=-0.24, FDR=0.001) and IgG heavy chain proteins (rg=-0.68, FDR=0.22). Gene set enrichment analyses (FDR<0.2) based on phenotypic and genetic associations of protein abundances with subsequent disease resilience revealed many pathways related to the immune system that were unfavorably associated with subsequent disease resilience, especially the innate immune system. It was not possible to determine whether the observed levels of these proteins reflected baseline levels in these young and visually healthy pigs or were the result of response to environmental disturbances that the pigs were exposed to before sample collection. Nevertheless, results show that, under these conditions, the abundances of proteins in some immune related pathways can be used as phenotypic and genetic predictors of disease resilience and have the potential for use in pig breeding and management.

19 September 2023 in EBioMedicine
Verified
Journal Article
Open access
YCYulu Chen
Yulu Chen
KMKevin Mendez
Kevin Mendez
SBSofina Begum
Sofina Begum
EDEmily Dean
Emily Dean
HCHaley Chatelaine
Haley Chatelaine
Jessica Lasky-SuJessica Lasky-Su
Jessica Lasky-Su
As new infectious diseases (ID) emerge and others continue to mutate, there remains an imminent threat, especially for vulnerable individuals. Yet no generalizable framework exists to identify the at-risk group prior to infection. Metabolomics has the advantage of capturing the existing physiologic state, unobserved via current clinical measures. Furthermore, metabolomics profiling during acute disease can be influenced by confounding factors such as indications, medical treatments, and lifestyles. We employed metabolomic profiling to cluster infection-free individuals and assessed their relationship with COVID severity and influenza incidence/recurrence. We identified a metabolomic susceptibility endotype that was strongly associated with both severe COVID (ORICUadmission = 6.7, p-value = 1.2 × 10-08, ORmortality = 4.7, p-value = 1.6 × 10-04) and influenza (ORincidence = 2.9; p-values = 2.2 × 10-4, βrecurrence = 1.03; p-value = 5.1 × 10-3). We observed similar severity associations when recapitulating this susceptibility endotype using metabolomics from individuals during and after acute COVID infection. We demonstrate the value of using metabolomic endotyping to identify a metabolically susceptible group for two-and potentially more-IDs that are driven by increases in specific amino acids, including microbial-related metabolites such as tryptophan, bile acids, histidine, polyamine, phenylalanine, and tyrosine metabolism, as well as carbohydrates involved in glycolysis. These metabolites may be identified prior to infection to enable protective measures for these individuals. The Longitudinal EMR and Omics COVID-19 Cohort (LEOCC) and metabolomic profiling were supported by the National Heart, Lung, and Blood Institute and the Intramural Research Program of the National Center for Advancing Translational Sciences, National Institutes of Health.

28 June 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NPNicole Prince
Nicole Prince
Rachel KellyRachel Kelly
Rachel Kelly
SCSu Chu
Su Chu
PKPriyadarshini Kachroo
Priyadarshini Kachroo
YCYulu Chen
Yulu Chen
Jessica Lasky-SuJessica Lasky-Su
Jessica Lasky-Su
Respiratory infections are a leading cause of morbidity and mortality in early life, and recurrent infections increase the risk of developing chronic diseases. The maternal environment during pregnancy can impact offspring health, but the factors leading to increased infection proneness have not been well characterized during this period. Steroids have been implicated in respiratory health outcomes and may similarly influence infection susceptibility. Our objective was to describe relationships between maternal steroid levels and offspring infection proneness. Using adjusted Poisson regression models, we evaluated associations between sixteen androgenic and corticosteroid metabolites during pregnancy and offspring respiratory infection incidence across two pre-birth cohorts (N = 774 in VDAART and N = 729 in COPSAC). Steroid metabolites were measured in plasma samples from pregnant mothers across all trimesters of pregnancy by ultrahigh-performance-liquid-chromatography/mass-spectrometry. We conducted further inquiry into associations of steroids with related respiratory outcomes: asthma and lung function spirometry. Higher plasma corticosteroid levels in the third trimester of pregnancy were associated with lower incidence of offspring respiratory infections (P = 4.45 × 10–7 to 0.002) and improved lung function metrics (P = 0.020–0.036). Elevated maternal androgens were generally associated with increased offspring respiratory infections and worse lung function, with some associations demonstrating nominal significance at P < 0.05, but these trends were inconsistent across individual androgens. Increased maternal plasma corticosteroid levels in the late second and third trimesters were associated with lower infections and better lung function in offspring, which may represent a potential avenue for intervention through corticosteroid supplementation in late pregnancy to reduce offspring respiratory infection susceptibility in early life.Clinical Trial Registry information: VDAART and COPSAC were originally conducted as clinical trials; VDAART: ClinicalTrials.gov identifier NCT00920621; COPSAC: ClinicalTrials.gov identifier NCT00798226.

15 June 2026 in medRxiv
Verified
Preprint
Open access
JHJuan F. De la Hoz
Juan F. De la Hoz
YLYounga Heather Lee
Younga Heather Lee
JTJustin D. Tubbs
Justin D. Tubbs
WMWilliam Meyerson
William Meyerson
MCMihael Cudic
Mihael Cudic
JSJordan Smoller
Jordan Smoller
Importance: Individuals with psychiatric disorders face elevated cardiometabolic risk which is linked to increased mortality. The extent to which this reflects shared pathogenesis or the downstream effects of illness and treatment remains poorly understood. Objective: To characterize the direct pleiotropic effects of psychiatric genetic liability on circulating metabolites and aggregate cardiometabolic risk, independent of psychiatric diagnosis and psychotropic medication use. Design, Setting and Participants: Cross-sectional analysis of Mass General Brigham Biobank participants with metabolomic profiling, genomic data, and linked electronic health records. Exposures: Genetic liability to nine psychiatric disorders quantified using polygenic risk scores (PRS): attention deficit/hyperactivity disorder (ADHD), anorexia nervosa (ANO), anxiety disorder (ANX), autism spectrum disorder (ASD), bipolar disorder (BD), major depressive disorder (MDD), PTSD, schizophrenia (SCZ), and substance use disorder (SUD). Main Outcomes and Measures: 249 circulating metabolites and four metabolomic risk scores (MRS) for type 2 diabetes, myocardial infarction, ischemic stroke, and vascular dementia. PRS-metabolite associations were estimated using nested models adjusting for lifetime psychiatric diagnosis and psychotropic medication use. Results: Across 25,290 participants, we identified 604 significant PRS-metabolite associations (Bonferroni p< 1.36 × 10 -4 ), of which 89% persisted after adjustment for lifetime diagnosis and medication use, suggesting that the direct genetic effects on metabolism are largely independent of illness or treatment. PRS for MDD, PTSD, and ADHD showed the most extensive dysregulation, with a transdiagnostic pattern of elevated lipids and systemic inflammation, specifically triglycerides (β = 0.04 to 0.05, all p< 4.4 ×10 -13 ) and glycoprotein acetyls (β = 0.05, all p< 2.2 ×10 -16 ). Notably, PRS for SCZ and BD showed minimal metabolite dysregulation despite having the strongest association with their target diagnoses. PRS for MDD, PTSD, ADHD, and SUD were associated with increased MRS across cardiometabolic conditions (β = 0.03 to 0.08, all p< 2.1 ×10 -4 ). Sensitivity analyses controlling for BMI or excluding participants without any psychiatric history (N: 21,305 and 11,150, respectively) showed a similar pattern. Conclusions and Relevance: Psychiatric genetic liability is associated with systemic metabolic dysregulation independent of illness onset or treatment, supporting a partially pleiotropic basis for psychiatric-cardiometabolic comorbidity. Key findings: Question: Does genetic liability to psychiatric disorders influence peripheral metabolism independent of psychiatric diagnosis and treatment? Findings: In 25,290 participants, polygenic scores for major depressive disorder, posttraumatic stress disorder, and attention deficit hyperactivity disorder showed widespread associations with metabolic dysregulation, such as elevated triglycerides and systemic inflammation, which persisted after adjusting for diagnosis and medication use. Polygenic scores for schizophrenia and bipolar disorder showed minimal metabolite associations despite their well-established cardiometabolic burden. Meaning: Shared genetic pathways partially underlie psychiatric and cardiometabolic comorbidity, implicating transdiagnostic biomarker profiles.

24 October 2025 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
Jessica Lasky-SuJessica Lasky-Su
Jessica Lasky-Su
KMKevin M Mendez
Kevin M Mendez
NPNicole Prince
Nicole Prince
YCYulu Chen
Yulu Chen
Rachel KellyRachel Kelly
Rachel Kelly